Replies to post #193159 on Biotech Values

[mcbio]

EPIX/TKAI -

I think the one big caveat on TKAI is that the P2 data in ARV7 patients specifically was of an ad hoc nature and there is some debate at least on whether the patients truly were ARV7 patients.

Sorry, I obviously meant post hoc in my prior post, not ad hoc. Ad hoc would have probably erased some questions on TKAI. ; )

[biomaven0]

I've been told there is a lot of skepticism surrounding the Tokai drug. But can't say I've done a deep dive myself.

Peter